Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics

Experimental Brain Research
L J GareyS R Hirsch

Abstract

We utilised postmortem brain tissue to quantify sections of left and right orbitofrontal cortex (area 11) from nine schizophrenic and eight control patients from the Charing Cross Prospective Schizophrenia Study immunostained for the presence of the kainate receptor (GluR5/6/7). The numerical density of neurons immunopositive for kainate receptor was measured. Other sections from the same blocks were stained with cresyl violet to determine the total neuronal numerical density. All measurements were made blind: diagnoses were only revealed by a third party after measurements were completed. There was a significant reduction (21%) in numerical density of kainate receptor-positive neurons in both cortices in the schizophrenic group (488 cells/mm2) compared to that in the control group (618 cells/mm2) (P=0.033). Nissl-stained tissue showed no significant difference in total neuronal numerical density between control and schizophrenic groups. These observations suggest that there are actually fewer kainate receptor-positive neurons in schizophrenic orbitofrontal cortex. There was no correlation of reduced kainate receptor-positive cell number with age at death, postmortem interval, or other possibly confounding neuropathology. Our r...Continue Reading

References

Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·S R Zukin, R S Zukin
Apr 15, 1992·The Journal of Comparative Neurology·R S Petralia, R J Wenthold
Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Jan 1, 1991·Schizophrenia Bulletin·H Y Meltzer
Dec 15, 1991·Biological Psychiatry·A D ShermanR Waziri
Feb 1, 1989·Clinical Neuropharmacology·S I DeutschJ M Morihisa
Jun 1, 1989·Journal of Neurochemistry·J F DeakinA J Cross
Dec 1, 1986·Brain : a Journal of Neurology·J GrafmanD Amin
Oct 10, 1983·Neuroscience Letters·T NishikawaM Toru
May 1, 1981·British Medical Bulletin·J A Gray
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Jun 1, 1994·Trends in Pharmacological Sciences·J M Henley
Jan 1, 1993·Schizophrenia Bulletin·J A Lieberman, A R Koreen
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J KornhuberP Riederer
Dec 1, 1993·The Japanese Journal of Psychiatry and Neurology·K SatohY Yonekura
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
Apr 1, 1997·Pharmacology, Biochemistry, and Behavior·S R HirschJ de Belleroche
Jul 1, 1997·Brain Research. Molecular Brain Research·D J Healy, J H Meador-Woodruff
Jan 1, 1997·Methods in Molecular Biology·S J Newman, S M Gentleman
Oct 15, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·L J GareyS R Hirsch
Jan 23, 1999·Biological Psychiatry·L D Selemon, P S Goldman-Rakic
Jan 13, 2000·Archives of General Psychiatry·L A Glantz, D A Lewis
Apr 5, 2000·Journal of Neuropathology and Experimental Neurology·K RadewiczR Reynolds

❮ Previous
Next ❯

Citations

Apr 3, 2012·Molecular and Cellular Neurosciences·Vaishali A Kulkarni, Bonnie L Firestein
Feb 25, 2011·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Zoë D Théodoridou, Lazaros C Triarhou
Dec 7, 2010·CNS Neuroscience & Therapeutics·Carlos Matute
May 10, 2018·Cognitive Neuropsychology·Cristina Romani
Jul 8, 2014·Brain Connectivity·Robert Turner, Stefan Geyer
Oct 10, 2013·Nature Reviews. Neuroscience·L C GreigJ D Macklis
Jan 1, 2012·Biomolecules & Therapeutics·Maria D RubioJames H Meador-Woodruff
Apr 29, 2021·Neuropharmacology·Sari E LauriTomi Taira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
E ScarrB Dean
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Monica BeneytoJames H Meador-Woodruff
© 2021 Meta ULC. All rights reserved